Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 May 18;27(8):928–935. doi: 10.1158/1055-9965.EPI-18-0093

Table 1.

Baseline characteristics of the participants by coffee consumption in the Multiethnic Cohort Studya

Coffee consumption
Total
None 1-3 cups/month 1-6 cups/week 1 cup/day 2-3 cups/day ≥4 cups/day
Number of participants 26,985 12,011 22,244 51,536 43,033 11,911 167,720
Age at cohort entry (years) 58.7 (9.2) 59.4 (8.9) 59.4 (8.8) 61.1 (8.7) 58.8 (8.6) 57.5 (8.2) 59.5 (8.8)
Female 15,894 (58.9) 7,036 (58.6) 11,640 (52.3) 28,659 (55.6) 22,455 (52.2) 5,398 (45.3) 91,082 (54.3)
Race/ethnicity
 African American 6,919 (25.6) 2,826 (23.5) 4,622 (20.8) 8,240 (16.0) 4,421 (10.3) 912 (7.7) 27,940 (16.7)
 Native Hawaiian 2,716 (10.1) 1,053 (8.8) 1,796 (8.1) 3,502 (6.8) 2,489 (5.8) 727 (6.1) 12,283 (7.3)
 Japanese American 6,863 (25.4) 3,433 (28.6) 6,206 (27.9) 16,862 (32.7) 12,629 (29.3) 3,021 (25.4) 49,014 (29.2)
 Latino 3,965 (14.7) 2,312 (19.2) 5,516 (24.8) 11,620 (22.5) 11,172 (26.0) 3,214 (27.0) 37,799 (22.5)
 White 6,522 (24.2) 2,387 (19.9) 4,104 (18.4) 11,312 (21.9) 12,322 (28.6) 4,037 (33.9) 40,684 (24.3)
Body mass index (kg/m2) 26.8 (5.7) 26.8 (5.5) 27.1 (5.3) 26.3 (4.9) 26.4 (4.8) 26.5 (4.8) 26.6 (5.1)
Smoking status
 Never 15,814 (58.6) 6,566 (54.7) 10,919 (49.1) 23,123 (44.9) 16,481 (38.3) 3,086 (25.9) 75,989 (45.3)
 Former 8,534 (31.6) 4,178 (34.8) 8,417 (37.8) 20,735 (40.2) 17,865 (41.5) 4,607 (38.7) 64,336 (38.4)
 Current 2,637 (9.8) 1,267 (10.5) 2,908 (13.1) 7,678 (14.9) 8,687 (20.2) 4,218 (35.4) 27,395 (16.3)
Pack-years among ever smokers 15.8 (14.9) 15.3 (14.5) 15.5 (14.3) 17.7 (15.5) 19.3 (16.1) 24.6 (17.4) 18.2 (15.8)
History of diabetes 3,141 (11.6) 1,480 (12.3) 2,881 (13.0) 6,080 (11.8) 4,412 (10.3) 1,220 (10.2) 19,214 (11.5)
Alcohol intake (g/day) 6.5 (24.6) 6.8 (23.4) 7.5 (21.5) 10.1 (25.7) 10.2 (25.4) 11.0 (29.7) 9.0 (25.1)
Education
 ≤ 12th grade 10,762 (40.1) 5,029 (42.1) 10,205 (46.1) 24,052 (46.9) 17,839 (41.6) 4,945 (41.7) 72,832 (43.6)
 Vocational/some college 8,018 (29.9) 3,517 (29.4) 6,315 (28.5) 15,115 (29.4) 12,879 (30.0) 3,449 (29.1) 49,293 (29.5)
 ≥ college graduate 8,067 (30.0) 3,403 (28.5) 5,615 (25.4) 12,160 (23.7) 12,145 (28.3) 3,473 (29.3) 44,863 (26.9)
Physical activity (hours/day)b 0.39 (0.85) 0.35 (0.77) 0.39 (0.82) 0.38 (0.83) 0.40 (0.83) 0.45 (0.90) 0.39 (0.83)
Menopausal status and MHT use among women
 Premenopausal 2,759 (19.1) 1,067 (16.4) 1,778 (16.6) 3,294 (12.3) 3,511 (16.9) 918 (18.5) 13,327 (15.7)
 Postmenopausal-never 5,428 (37.6) 2,373 (36.5) 4,161 (38.9) 10,487 (39.2) 7,556 (36.4) 1,899 (38.4) 31,767 (37.3)
 Postmenopausal-former 2,355 (16.3) 1,102 (17.0) 1,778 (16.6) 4,783 (17.9) 3,443 (16.6) 837 (16.9) 14,349 (16.9)
 Postmenopausal-current 3,877 (26.9) 1,955 (30.1) 2,975 (27.8) 8,170 (30.6) 6,271 (30.2) 1,297 (26.2) 25,658 (30.2)

Abbreviation: MHT, menopausal hormone therapy.

a

Mean (SD) for continuous variables and n (column %) for categorical variables.

b

Hours spent in vigorous activity per day.